Avivagen Inc. (VIVXF)
VIVXF Stock Price Chart
Explore Avivagen Inc. interactive price chart. Choose custom timeframes to analyze VIVXF price movements and trends.
VIVXF Company Profile
Discover essential business fundamentals and corporate details for Avivagen Inc. (VIVXF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2 May 2013
Employees
13.00
Website
https://www.avivagen.comCEO
G. F. Kym Anthony
Description
Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.
VIVXF Financial Timeline
Browse a chronological timeline of Avivagen Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Sept 2024
Earnings released on 10 Jul 2024
Earnings released on 29 Apr 2024
Earnings released on 3 Jan 2024
Earnings released on 28 Sept 2023
EPS came in at -$0.01 , while revenue for the quarter reached $30.35K .
Earnings released on 6 Jun 2023
EPS came in at -$0.01 , while revenue for the quarter reached $57.13K .
Earnings released on 16 Mar 2023
EPS came in at -$0.01 , while revenue for the quarter reached $49.46K .
Earnings released on 21 Feb 2023
EPS came in at -$0.01 falling short of the estimated -$0.01 by -49.93%, while revenue for the quarter reached $389.28K , beating expectations by +203.15%.
Earnings released on 16 Sept 2022
EPS came in at -$0.02 falling short of the estimated -$0.02 by -19.98%, while revenue for the quarter reached $37.88K , missing expectations by -75.75%.
Earnings released on 15 Jun 2022
EPS came in at -$0.02 falling short of the estimated -$0.02 by -19.98%, while revenue for the quarter reached $68.91K , missing expectations by -74.67%.
Earnings released on 30 Mar 2022
EPS came in at -$0.03 falling short of the estimated -$0.03 by -20.00%, while revenue for the quarter reached $213.57K , missing expectations by -32.12%.
Earnings released on 19 Jan 2022
EPS came in at -$0.02 matching the estimated -$0.02, while revenue for the quarter reached $297.88K , missing expectations by -73.64%.
Earnings released on 29 Sept 2021
EPS came in at -$0.02 , while revenue for the quarter reached $404.58K .
Earnings released on 2 Jun 2021
EPS came in at -$0.03 falling short of the estimated -$0.02 by -60.00%, while revenue for the quarter reached $129.64K .
Earnings released on 3 Mar 2021
EPS came in at -$0.02 , while revenue for the quarter reached $204.61K .
Earnings released on 15 Dec 2020
EPS came in at -$0.02 , while revenue for the quarter reached $216.69K .
VIVXF Stock Performance
Access detailed VIVXF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.